Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAPI: Parasitic Infections in HIV
NCT05323396Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of albendazole, praziquantel and metronidazole in intestinal parasitic infection (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Number of Participants With and Without Intestinal Parasitic Infection, Mean Soluble CD14 Levels and 5 more. Started May 2022; status: completed.
02
Drugs
albendazolepraziquantelmetronidazole
03
Conditions
intestinal parasitic infection
Beyond the preview
Go deeper on NCT05323396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323396.